Marshall Wace’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-388,955
| Closed | -$8.04M | – | 2412 |
|
|
2024
Q1 | $8.04M | Buy |
+388,955
| New | +$8.04M | 0.01% | 724 |
|
|
2023
Q3 | – | Sell |
-89,115
| Closed | -$775K | – | 1989 |
|
|
2023
Q2 | $775K | Buy |
89,115
+41,291
| +86% | +$359K | ﹤0.01% | 1453 |
|
|
2023
Q1 | $141K | Buy |
47,824
+29,353
| +159% | +$86.3K | ﹤0.01% | 1960 |
|
|
2022
Q4 | $64.6K | Buy |
+18,471
| New | +$64.6K | ﹤0.01% | 2229 |
|
|
2022
Q1 | – | Sell |
-11,608
| Closed | -$142K | – | 2807 |
|
|
2021
Q4 | $142K | Buy |
+11,608
| New | +$142K | ﹤0.01% | 2593 |
|
|
2021
Q3 | – | Sell |
-37,746
| Closed | -$340K | – | 2522 |
|
|
2021
Q2 | $340K | Sell |
37,746
-69,201
| -65% | -$623K | ﹤0.01% | 1792 |
|
|
2021
Q1 | $1.09M | Buy |
+106,947
| New | +$1.09M | 0.01% | 1365 |
|